Annovis Bio Inc
Change company Symbol lookup
Select an option...
ANVS Annovis Bio Inc
GOVT iShares U.S. Treasury Bond ETF
BAC Bank of America Corp
$NQASPA50JPYN Nasdaq ASPA Industrials Net Total Re
SNP China Petroleum & Chemical Corp
GAEC Gulf Alternative Energy Corp
RDBX Redbox Entertainment Inc
AFG American Financial Group Inc
MRNA Moderna Inc
PFE Pfizer Inc
Go

Health Care : Biotechnology |
Company profile

Annovis Bio, Inc. is a clinical-stage drug platform company. The Company is engaged in developing treatments for neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s disease in Down syndrome (AD-DS). The Company's lead compound, ANVS401, is an orally administered drug being developed for chronic indications such as AD, PD and AD-DS. The Company's ANVS405 compound is being developed for acute indications, focused on protecting the brain after Traumatic brain injury (TBI) and/or stroke. ANVS405 is the same compound as ANVS401, but it is given intravenously in cases of acute head and brain trauma. The Company is also developing its compound, ANVS301 to increase cognitive capability in later stages of AD and dementia.

Closing Price
$25.76
Day's Change
-0.10 (-0.39%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.21
Day's Low
24.22
Volume
(Light)
Volume:
46,480

10-day average volume:
186,337
46,480
  • Prev Close
    25.86
  • Today's Open
    25.00
  • Day's Range
    24.22-26.21
  • Avg Vol (10-day)
    186.3K
  • Last (time)
    5:00p ET 11/26/21
  • Last (size)
    1
  • 52-Wk Range
    5.25 - 132.00
    LowHigh
  • (12/01/20 - 07/23/21)
    390.67%
  • 171.6%
  • Market Cap
    208.7M
  • Shares Outstanding
    8.1M
  • -1.40
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 17.49
  • (% of float 11/15/21)
    9.35

Latest News

November 15, 2021
9:01 am ET
Newsfile
November 12, 2021
10:27 am ET
Newsfile
November 09, 2021
8:31 am ET
Newsfile
November 02, 2021
8:31 am ET
Newsfile
October 18, 2021
8:10 am ET
Accesswire
October 15, 2021
8:56 pm ET
PR Newswire
4:22 pm ET
Newsfile
10:01 am ET
Newsfile
October 14, 2021
4:20 pm ET
Newsfile
October 13, 2021
11:03 am ET
Accesswire
10:45 am ET
Accesswire
10:20 am ET
PR Newswire
8:50 am ET
Newsfile
8:31 am ET
Accesswire
October 12, 2021
9:07 pm ET
Newsfile
8:20 pm ET
Accesswire
6:41 pm ET
Newsfile
5:29 pm ET
Newsfile
4:30 pm ET
Accesswire
4:30 pm ET
Accesswire
3:38 pm ET
Newsfile
3:10 pm ET
Accesswire
3:04 pm ET
Newsfile
12:45 pm ET
Accesswire
6:29 am ET
Newsfile
5:40 am ET
Accesswire
October 11, 2021
5:14 pm ET
Accesswire
4:27 pm ET
Accesswire
4:15 pm ET
Accesswire
11:14 am ET
Newsfile
9:35 am ET
Newsfile
9:10 am ET
Accesswire
October 10, 2021
4:07 pm ET
Accesswire
10:36 am ET
Accesswire
October 09, 2021
10:24 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.